Beibei Guo

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 12

Top Topics

Immune Response

End Stage Renal Disease

Top Venues

Pharmaceutical statistics

Statistics in medicine

Statistical methods in medical research

This page only lists publications with an associated author ORCID identifier.

Publications

Li-Hsiang Lin, Yan Han, Rui Zhang, Beibei Guo
Biomarker-based precision dose finding for immunotherapy combined with radiotherapy. Biometrical journal. Biometrische Zeitschrift (2023)
Mu Shan, Beibei Guo, Hao Liu, Qian Li, Yong Zang
Bayesian order constrained adaptive design for phase II clinical trials evaluating subgroup-specific treatment effect. Statistical methods in medical research (2023)
Beibei Guo, Ying Yuan
DROID: Dose-ranging approach to optimizing dose in oncology drug development. Biometrics (2023)
Beibei Guo, Ying Yuan
DROID: dose-ranging approach to optimizing dose in oncology drug development. Biometrics (2023)
Beibei Guo, Yong Zang, Li-Hsiang Lin, Rui Zhang
A Bayesian phase I/II design to determine subgroup-specific optimal dose for immunotherapy sequentially combined with radiotherapy. Pharmaceutical statistics (2022)
Beibei Guo, Yong Zang
A Bayesian phase I/II biomarker-based design for identifying subgroup-specific optimal dose for immunotherapy. Statistical methods in medical research 31 (6) (2022)
Yifei Zhang, Beibei Guo, Sha Cao, Chi Zhang, Yong Zang
SCI: A Bayesian adaptive phase I/II dose-finding design accounting for semi-competing risks outcomes for immunotherapy trials. Pharmaceutical statistics 21 (5) (2022)
Beibei Guo, Yong Zang
BIPSE: A biomarker-based phase I/II design for immunotherapy trials with progression-free survival endpoint. Statistics in medicine (2021)
Beibei Guo, Yong Zang
BILITE: A Bayesian randomized phase II design for immunotherapy by jointly modeling the longitudinal immune response and time-to-event efficacy. Statistics in medicine 39 (29) (2020)
Yong Zang, Beibei Guo, Yan Han, Sha Cao, Chi Zhang
A Bayesian adaptive marker-stratified design for molecularly targeted agents with customized hierarchical modeling. Statistics in medicine 38 (15) (2019)
Beibei Guo, Yong Zang
A Bayesian adaptive phase II clinical trial design accounting for spatial variation. Statistical methods in medical research 28 (10-11) (2018)
Beibei Guo, Daniel Li, Ying Yuan
SPIRIT: A seamless phase I/II randomized design for immunotherapy trials. Pharmaceutical statistics 17 (5) (2018)